JP Morgan Chase’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

JP Morgan Chase’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-7,076	Closed	-$3K	–	5173
2016 Q1	$3K	Hold	7,076	–	–	﹤0.01%	4493
2015 Q4	$5K	Buy	+7,076	New	+$7.3K	﹤0.01%	4371

JP Morgan Chase's ALXA Position: Q2 2016 in Review

JP Morgan Chase sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 7,076 shares — an estimated $3K sold.

JP Morgan Chase first reported a position in ALXA in Q4 2015 and held it in 2 quarters. The position peaked at $5K in Q4 2015. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

JP Morgan Chase reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
JP Morgan Chase sold 7,076 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $3K.
JP Morgan Chase first reported a position in Alexza Pharmaceuticals Inc in Q4 2015 and held it in 2 quarters.
JP Morgan Chase's Alexza Pharmaceuticals Inc position peaked at $5K in Q4 2015.
0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on JP Morgan Chase's 13F filing for Q2 2016, filed 8 Aug 2016.